Why the study?
Although isolated inspiratory muscle training provides clinical benefits in chronic heart failure, the rationale of combining it with exercise training in cardiac rehabilitation settings remained to be confirmed.
Does the addition of inspiratory muscle training to exercise-based cardiac rehabilitation improve inspiratory muscle strength, hemodynamics, and quality of life in male patients with ischemic heart failure?
Does the addition of inspiratory muscle training to exercise-based cardiac rehabilitation improve inspiratory muscle strength, hemodynamics, and quality of life in male patients with ischemic heart failure?
Adding inspiratory muscle training to standard exercise-based cardiac rehabilitation improves inspiratory muscle strength, hemodynamics, and quality of life in male patients with ischemic heart failure.
Answers are grounded in this paper and cite their sources.
Adds limited evidence on combined IMT plus exercise training in CHF; leaves open whether benefits exceed sham plus training.
Background: Evidence supports the clinical benefits of isolated inspiratory muscle training (IMT) in patients with chronic heart failure (CHF); however, the rationale of IMT in combination with exercise training in cardiac rehabilitation settings for CHF has yet to be confirmed. Objective: ), selected hemodynamic variables, and health-related quality of life (HRQoL) compared to sham-IMT combined with AT/RT in patients with CHF. Absolute mean changes from baseline (Δ) in the outcome measures were statistically analyzed as independent outcomes. Results: ΔPImax, ΔRHR, ΔHR reserve, and ΔMLwHFQ total score were significantly greater in the study group than in the control group (p < 0.05). In addition, ΔRPP showed an observed difference in favor of the study group with a tendency towards statistical significance (p = 0.07). Conclusions: IMT could be a successful complementary intervention to exercise-based cardiac rehabilitation programs comprising AT/RT, yielding greater improvements in PImax, RHR, HR reserve, and HRQoL in male patients with ischemic heart failure (NYHA class II-III).
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: